We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.83B
AUM Growth
+$108M
(+2.3%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
12.94%
Holding
1,335
New
249
Increased
372
Reduced
442
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$35.5M |
| 2 |
CVS Health
CVS
|
+$32.5M |
| 3 |
Biogen
BIIB
|
+$24.9M |
| 4 |
Citigroup
C
|
+$23.8M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$31.7M |
| 2 |
Comcast
CMCSA
|
+$23.5M |
| 3 |
Verizon
VZ
|
+$23.2M |
| 4 |
Amazon
AMZN
|
+$22.2M |
| 5 |
Eli Lilly
LLY
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 13.7% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICAD
1001
DELISTED
iCAD Inc
ICAD
| $210K | ﹤0.01% |
+40,297
| New | +$211K |
|
|
FCSC
1002
DELISTED
Fibrocell Science Inc.
FCSC
| $210K | ﹤0.01% |
12,187
+11,127
| +1,050% | +$347K |
|
1003
AXT Inc
AXTI
$3.09B
| $208K | ﹤0.01% |
+65,100
| New | +$200K |
|
1004
Bank of Marin Bancorp
BMRC
$466M
| $208K | ﹤0.01% |
+8,620
| New | +$212K |
|
|
CBIO
1005
Crescent Biopharma
CBIO
$602M
| $208K | ﹤0.01% |
287
+14
| +5% | +$9.65K |
|
1006
Tonix Pharmaceuticals
TNXP
$157M
| – | – |
0
| – | – |
|
1007
Itron
ITRI
$3.73B
| $206K | ﹤0.01% |
+4,780
| New | +$202K |
|
|
CGI
1008
DELISTED
Celadon Group Inc
CGI
| $206K | ﹤0.01% |
25,175
-78,495
| -76% | -$762K |
|
1009
Amtech Systems
ASYS
$278M
| $201K | ﹤0.01% |
+33,634
| New | +$214K |
|
1010
Triumph Financial Inc
TFIN
$1.84B
| $200K | ﹤0.01% |
12,526
| – | – |
|
|
BSQR
1011
DELISTED
BSQUARE Corporation
BSQR
| $200K | ﹤0.01% |
35,807
-10,000
| -22% | -$57.1K |
|
1012
Amkor Technology
AMKR
$16.1B
| $196K | ﹤0.01% |
+34,000
| New | +$198K |
|
1013
Bristow Group
VTOL
$1.35B
| $195K | ﹤0.01% |
10,385
-8,516
| -45% | -$164K |
|
|
BHBK
1014
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $193K | ﹤0.01% |
13,100
+700
| +6% | +$10K |
|
1015
Heron Therapeutics
HRTX
$86.3M
| $191K | ﹤0.01% |
10,560
-28,100
| -73% | -$549K |
|
|
CTG
1016
DELISTED
Computer Task Group, Inc.
CTG
| $190K | ﹤0.01% |
38,266
| – | – |
|
|
OMED
1017
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $188K | ﹤0.01% |
+15,290
| New | +$186K |
|
1018
Dare Bioscience
DARE
$19.2M
| $187K | ﹤0.01% |
+737
| New | +$236K |
|
|
ENZ
1019
DELISTED
Enzo Biochem, Inc.
ENZ
| $184K | ﹤0.01% |
30,739
+2,900
| +10% | +$16.1K |
|
1020
Frontline
FRO
$8.75B
| $183K | ﹤0.01% |
+23,300
| New | +$192K |
|
|
WMAR
1021
DELISTED
West Marine Inc
WMAR
| $183K | ﹤0.01% |
21,800
-1,400
| -6% | -$12.9K |
|
1022
Upland Software
UPLD
$12M
| $181K | ﹤0.01% |
2,370
-590
| -20% | -$42.3K |
|
|
IVAC
1023
DELISTED
Intevac Inc
IVAC
| $181K | ﹤0.01% |
31,919
-10,163
| -24% | -$50.3K |
|
|
HWCC
1024
DELISTED
Houston Wire & Cable Company
HWCC
| $181K | ﹤0.01% |
34,383
-10,195
| -23% | -$62.2K |
|
|
CJES
1025
DELISTED
C&J ENERGY SVCS LTD
CJES
| $181K | ﹤0.01% |
301,193
-552,337
| -65% | -$515K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2016 Portfolio in Review
As of Q2 2016, Jacobs Levy Equity Management held 1,335 positions worth $4.83B, up 2.3% from $4.72B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2016 filing shows 249 new, 372 increased, 442 reduced and 194 closed positions. Its largest new stake was CVS Health: 325,716 shares worth $31.2M. The largest sale was Targa Resources, an estimated $31.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2016 buy was CVS Health: 325,716 shares worth $31.2M.
- Jacobs Levy Equity Management added most to Microsoft in Q2 2016, an estimated $35.5M increase.
- Jacobs Levy Equity Management's biggest Q2 2016 reduction was Comcast, cutting an estimated $23.5M.
- Jacobs Levy Equity Management fully exited Targa Resources in Q2 2016, selling an estimated $31.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.83B portfolio in Q2 2016.
- Jacobs Levy Equity Management opened 249 new positions and closed 194 in Q2 2016.
- Jacobs Levy Equity Management's portfolio value rose 2.3% quarter-over-quarter to $4.83B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.